Pentobarbital decreases effects of sufentanil SL by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Modify Therapy/Keep track of Closely. Coadministration of CYP3A4 inducers may lessen sufentanil levels and efficacy, perhaps precipitating withdrawal syndrome in individuals who've formulated Actual physical dependence to sufentanil. Discontinuation of concomitantly used CYP3A4 i... https://sodium-pentobarbital-in-h09875.fitnell.com/62355217/sodium-pentobarbital-sigma-secrets